Abstract
The murine monoclonal antibody OPG2 is an excellent paradigm of natural RGD ligands and binds specifically to alpha IIb beta 3 integrin. A reactive Arg103-Tyr104-Asp105 (RYD) tripeptide is located in an extended loop, the third complementarity-determining region of the heavy chain (H3). When compared to other RGD ligands, the RYD tripeptide of OPG2 is unique, in that the side chains are fixed in a stable orientation that we have defined by x-ray crystallography. In this study, we express OPG2 H chain segments (Fd) and kappa chains as components of active, Fab heterodimers by coinfection of Spodoptera frugiperda cell lines with recombinant baculoviruses containing cDNA specific for each protein. Recombinant AP7 Fd segments are generated from the parent OPG2 Fd segments by replacement of Tyr104 with Gly, while recombinant AP7E Fd segments are produced from AP7 Fd segments, by exchange of Asp105 with Glu. Neither the free Fd segments nor the free kappa chains of OPG2 or AP7 can bind to alpha IIb beta 3. The AP7 Fab fragment, like the parent OPG2 Fab, binds strongly to purified alpha IIb beta 3 but weakly, if at all, to purified alpha V beta 3. The affinity of OPG2 and AP7 Fab fragments for gel-filtered platelets, whether nonstimul...Continue Reading
References
Jun 15, 1978·Analytical Biochemistry·M A MarkwellN E Tolbert
Aug 25, 1992·Biochemistry·R Taub, M I Greene
Nov 13, 1992·Cell·A L MainI D Campbell
Jun 15, 1992·Thrombosis Research·J R SheuT F Huang
May 26, 1992·Biochemistry·R S McDowellR A Lazarus
Dec 5, 1991·European Journal of Biochemistry·C DalvitR Metternich
Jul 30, 1991·Biochemistry·V SaudekJ T Pelton
Jul 26, 1991·Science·M AdlerG Wagner
Jan 1, 1991·The Journal of Clinical Investigation·E Ruoslahti
Jan 1, 1991·The Journal of Cell Biology·M J ElicesM E Hemler
Nov 1, 1990·Proceedings of the Society for Experimental Biology and Medicine·R J GouldS Niewiarowski
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M S DennisR A Lazarus
Feb 28, 1986·Cell·E Ruoslahti, M D Pierschbacher
Mar 28, 1986·Science·R PytelaE Ruoslahti
Dec 1, 1987·The Journal of Clinical Investigation·K FurihataT J Kunicki
May 1, 1989·Virology·V A Luckow, M D Summers
Nov 15, 1985·Analytical Biochemistry·L A FitzgeraldD R Phillips
Oct 7, 1988·Science·S E D'SouzaE F Plow
Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·E F PlowM H Ginsberg
May 3, 1984·Nature·M D Pierschbacher, E Ruoslahti
Jan 7, 1994·Journal of Medicinal Chemistry·S ChengM D Pierschbacher
Feb 3, 1995·The Journal of Biological Chemistry·R KodandapaniK R Ely
Mar 4, 1994·Journal of Molecular Biology·C D DickinsonK R Ely
Citations
Aug 5, 1998·Toxicon : Official Journal of the International Society on Toxinology·H H Chang, S J Lo
May 5, 2001·The Biochemical Journal·B WattamX Lu
Dec 22, 1999·Clinical and Experimental Immunology·Y J Deng, A L Notkins
Apr 2, 1999·European Journal of Biochemistry·E KellenbergerJ F Lefèvre
Dec 1, 1996·Molecular Biology of the Cell·F Díaz-GonzálezM H Ginsberg
Mar 5, 1999·Critical Reviews in Toxicology·R HatiK K Bhattacharyya
Feb 14, 1997·The Journal of Biological Chemistry·T J KunickiB Felding-Habermann
May 16, 1997·The Journal of Biological Chemistry·L G JiaJ W Fox
Aug 23, 1996·The Journal of Biological Chemistry·T J KunickiS J Shattil
Feb 13, 2004·The Journal of Biological Chemistry·Paul H WeinrebShelia M Violette
Oct 29, 1998·Biochemical and Biophysical Research Communications·R KodandapaniK R Ely
Jul 31, 2009·Biochemistry·Roy R Hantgan, Mary C Stahle
Jan 28, 2010·Archives of Biochemistry and Biophysics·Eladio F SanchezJohannes A Eble